BindingDB logo
myBDB logout

null

SMILES: COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1

InChI Key: InChIKey=YWHMBIIFPMSMIF-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 274078   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Toll-like receptor 7


(Homo sapiens (Human))
BDBM274078
PNG
(US10071079, Example 864 | US10478424, Example 864)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1
Show InChI InChI=1S/C28H33FN6O2/c1-17(2)26-22-10-19(18-6-8-33(9-7-18)15-25(36)34-13-21(29)14-34)4-5-23(22)32-27(26)20-11-24(37-3)28-30-16-31-35(28)12-20/h4-5,10-12,16-18,21,32H,6-9,13-15H2,1-3H3
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.400n/an/an/an/an/a25



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10071079 (2018)


BindingDB Entry DOI: 10.7270/Q2VD71GV
More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM274078
PNG
(US10071079, Example 864 | US10478424, Example 864)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1
Show InChI InChI=1S/C28H33FN6O2/c1-17(2)26-22-10-19(18-6-8-33(9-7-18)15-25(36)34-13-21(29)14-34)4-5-23(22)32-27(26)20-11-24(37-3)28-30-16-31-35(28)12-20/h4-5,10-12,16-18,21,32H,6-9,13-15H2,1-3H3
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.5n/an/an/an/an/a25



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10071079 (2018)


BindingDB Entry DOI: 10.7270/Q2VD71GV
More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM274078
PNG
(US10071079, Example 864 | US10478424, Example 864)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1
Show InChI InChI=1S/C28H33FN6O2/c1-17(2)26-22-10-19(18-6-8-33(9-7-18)15-25(36)34-13-21(29)14-34)4-5-23(22)32-27(26)20-11-24(37-3)28-30-16-31-35(28)12-20/h4-5,10-12,16-18,21,32H,6-9,13-15H2,1-3H3
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.01E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10478424 (2019)


BindingDB Entry DOI: 10.7270/Q2QZ2DB0
More data for this
Ligand-Target Pair
Toll-like receptor 7


(Homo sapiens (Human))
BDBM274078
PNG
(US10071079, Example 864 | US10478424, Example 864)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1
Show InChI InChI=1S/C28H33FN6O2/c1-17(2)26-22-10-19(18-6-8-33(9-7-18)15-25(36)34-13-21(29)14-34)4-5-23(22)32-27(26)20-11-24(37-3)28-30-16-31-35(28)12-20/h4-5,10-12,16-18,21,32H,6-9,13-15H2,1-3H3
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.400n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10478424 (2019)


BindingDB Entry DOI: 10.7270/Q2QZ2DB0
More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM274078
PNG
(US10071079, Example 864 | US10478424, Example 864)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1
Show InChI InChI=1S/C28H33FN6O2/c1-17(2)26-22-10-19(18-6-8-33(9-7-18)15-25(36)34-13-21(29)14-34)4-5-23(22)32-27(26)20-11-24(37-3)28-30-16-31-35(28)12-20/h4-5,10-12,16-18,21,32H,6-9,13-15H2,1-3H3
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.5n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10478424 (2019)


BindingDB Entry DOI: 10.7270/Q2QZ2DB0
More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM274078
PNG
(US10071079, Example 864 | US10478424, Example 864)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC(=O)N2CC(F)C2)CC1
Show InChI InChI=1S/C28H33FN6O2/c1-17(2)26-22-10-19(18-6-8-33(9-7-18)15-25(36)34-13-21(29)14-34)4-5-23(22)32-27(26)20-11-24(37-3)28-30-16-31-35(28)12-20/h4-5,10-12,16-18,21,32H,6-9,13-15H2,1-3H3
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.01E+3n/an/an/an/an/a25



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10071079 (2018)


BindingDB Entry DOI: 10.7270/Q2VD71GV
More data for this
Ligand-Target Pair